EyePoint Pharmaceuticals has acquired 1 company, including 1 in the last 5 years.
EyePoint Pharmaceuticals’ largest acquisition to date was in 2018, when it acquired Icon Bioscience for $61M. EyePoint Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to EyePoint Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Advisors 3